Dashboard
Manage Tickers

ARWRARROWHEAD PHARMACEUTICALS, ...

Nasdaq arrowheadpharma.com


$ 22.92 $ -0.50 (-2.13 %)    

Tuesday, 14-May-2024 15:30:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.06 $ 1.29 (0.29 %)
DIA $ 395.82 $ 0.73 (0.18 %)
SPY $ 523.45 $ 1.27 (0.24 %)
TLT $ 90.86 $ 0.26 (0.29 %)
GLD $ 218.04 $ 0.21 (0.1 %)
$ 22.06
$ 23.42
$ 22.97 x 101
$ 0.00 x 0
$ 22.51 - $ 23.42
$ 20.67 - $ 40.89
1,949,574
na
2.72B
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-06-2024 12-31-2023 10-Q
3 11-29-2023 09-30-2023 10-K
4 08-07-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-06-2023 12-31-2022 10-Q
7 11-28-2022 09-30-2022 10-K
8 08-04-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-02-2022 12-31-2021 10-Q
11 11-22-2021 09-30-2021 10-K
12 08-05-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-04-2021 12-31-2020 10-Q
15 11-23-2020 09-30-2020 10-K
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-05-2020 12-31-2019 10-Q
19 11-25-2019 09-30-2019 10-K
20 08-05-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-Q
23 12-11-2018 09-30-2018 10-K
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-09-2018 12-31-2017 10-Q
27 12-12-2017 09-30-2017 10-K
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-06-2017 12-31-2016 10-Q
31 12-14-2016 09-30-2016 10-K
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-Q
35 12-14-2015 09-30-2015 10-K
36 08-04-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 02-09-2015 12-31-2014 10-Q
39 11-25-2014 09-30-2014 10-K
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-equal-weight-on-arrowhead-pharma-lowers-price-target-to-27
Morgan Stanley Maintains Equal-Weight on A...
05/13/2024 16:36:46

Morgan Stanley analyst Michael Ulz maintains Arrowhead Pharma (NASDAQ:ARWR) with a Equal-Weight and lowers the price target ...

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
05/13/2024 15:28:07

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $90 pric...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

chardan-capital-maintains-buy-on-arrowhead-pharma-maintains-60-price-target
Chardan Capital Maintains Buy on Arrowhead...
05/10/2024 14:20:55

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $60 price target.

arrowhead-pharma-q2-2024-gaap-eps-102-misses-012-estimate
Arrowhead Pharma Q2 2024 GAAP EPS $(1.02) ...
05/09/2024 20:09:26

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(...

amgen-reports-better-than-expected-q1-results-50m-milestone-payment
Amgen Reports Better-Than-Expected Q1 Resu...
05/02/2024 21:44:40

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company s...

Core News & Articles
Arrowhead Pharmaceuticals Earns $50M Miles...
05/02/2024 20:39:45

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced a $50 million milestone payment was received from Royalty Pharma ...

arrowhead-pharmaceuticals-has-dosed-the-first-subjects-in-a-phase-12a-trial-of-aro-cfb-the-companys-investigational-rna-interference-therapeutic-in-up-to-66-healthy-volunteers-and-patients-with-complement-mediated-kidney-disease
Arrowhead Pharmaceuticals Has Dosed The Fi...
04/24/2024 11:32:50

reported-sunday-arrowhead-pharmaceuticals-announces-new-phase-2-data-of-plozasiran-published-in-jama-cardiology-and-presented-at-acc24
Reported Sunday, Arrowhead Pharmaceuticals...
04/08/2024 06:54:27

- Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertr...

netapp-zoom-video-and-2-other-stocks-insiders-are-selling
NetApp, Zoom Video And 2 Other Stocks Insi...
04/04/2024 11:23:01

The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

arrowhead-pharmaceuticals-initiates-expanded-access-program-for-plozasiran
Arrowhead Pharmaceuticals Initiates Expand...
03/25/2024 12:05:29

eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday
EQT, Genie Energy And Other Big Stocks Mov...
03/11/2024 14:37:32

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

arrowhead-pharmaceuticals-says-it-initiated-phase-12a-study-of-aro-dm1-for-treatment-of-type-1-myotonic-dystrophy-company-adds-aro-dm1-is-designed-to-reduce-expression-of--dystrophia-myotonica-protein-kinase-dmpk-gene-in-muscle
Arrowhead Pharmaceuticals Says It Initiate...
03/08/2024 12:34:13

cooper-companies-reports-upbeat-results-joins-dell-netapp-tidewater-and-other-big-stocks-moving-higher-on-friday
Cooper Companies Reports Upbeat Results, J...
03/01/2024 16:18:21

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

blog-chatter-suggests-people-following-the-situation-have-heard-speculation-arrowhead-pharmaceuticals-recently-rebuffed-an-indicative-approach-pitched-at-around-45-a-share-shares-spiking-higher
Blog Chatter Suggests "People Following Th...
02/28/2024 18:20:49

watching-arrowhead-pharmaceuticals-traders-circulating-ma-blog-chatter-sugging-the-company-is-seeing-takeover-interest
Watching Arrowhead Pharmaceuticals; Trader...
02/28/2024 18:18:53

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
02/08/2024 20:27:36

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $90 pric...

citigroup-maintains-neutral-on-arrowhead-pharma-raises-price-target-to-34
Citigroup Maintains Neutral on Arrowhead P...
02/07/2024 19:07:28

Citigroup analyst Shawn Egan maintains Arrowhead Pharma (NASDAQ:ARWR) with a Neutral and raises the price target from $33 to...

cracking-the-code-understanding-analyst-reviews-for-arrowhead-pharma
Cracking The Code: Understanding Analyst R...
02/07/2024 17:01:02

rbc-capital-reiterates-outperform-on-arrowhead-pharma-maintains-50-price-target
RBC Capital Reiterates Outperform on Arrow...
02/07/2024 16:55:02

RBC Capital analyst Luca Issi reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and maintains $50 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION